| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996456 | Practical Radiation Oncology | 2016 | 8 Pages |
Abstract
Interstitial lung disease is associated with an increased risk of severe RP after SABR. Chest imaging should be reviewed for ILD before SABR, and the risk of fatal RP should be carefully weighed against the benefits of SABR in this subgroup.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Houda MD, Edith MD, Toni MD, Jean MD, Louise MD, David MD, Michel MD, Bernard MD, MSc, Dominic MSc, Dominique MSc, Marie-Pierre MD,